World News: 12:12 GMT Friday 10th August 2018. [Verona Pharma plc via Globe Newswire via SPi World News]
LONDON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces that, on August 9, 2018, Dr. David Ebsworth, Chairman of the Company, purchased 12,000 ordinary shares of 5 pence each in the Company (the “Ordinary Shares”) at a price of 120.00 pence per Ordinary Share. Following the acquisition, Dr. Ebsworth will have an interest in the Company of 147,787 Ordinary Shares, representing 0.14% of the Company’s issued share capital.
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
The Company also announces that, on August 9, 2018, it issued 58,112 new Ordinary Shares (the “New Ordinary Shares”) following the vesting of restricted stock units held by a former employee, Dr. Ken Newman. Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM, with dealings expected to commence on 16 August 2018 (“Admission”). Following Admission, the Company will have a total of 105,075,513 Ordinary Shares in issue each carrying one voting right. The Company does not hold any Ordinary Shares in Treasury. This figure of 105,075,513 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
For further information, please contact:
Globe Newswire: 12:12 GMT Friday 10th August 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.